We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current INO market cap is 52.98M. The company's latest EPS is USD -5.1769 and P/E is -0.39.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 388k | 103k | 0 | 101k | 0 |
| Operating Income | -35.34M | -27.61M | -31.61M | -33.53M | -27.02M |
| Net Income | -33.93M | -25M | -30.47M | -32.24M | -25.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.11M | 7.41M | 1.78M | 10.26M | 832k |
| Operating Income | -114.2M | -87.53M | -301.77M | -269.47M | -143.17M |
| Net Income | -119.36M | -166.41M | -303.66M | -279.82M | -135.12M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 193.1M | 170.95M | 129.11M | 133.8M | 107.06M |
| Total Liabilities | 54.94M | 53.6M | 34.67M | 37.06M | 33.52M |
| Total Equity | 138.16M | 117.35M | 94.44M | 96.74M | 73.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 143.95M | 539.77M | 495.94M | 348.53M | 170.95M |
| Total Liabilities | 138.55M | 78.63M | 96.27M | 126.17M | 53.6M |
| Total Equity | 5.41M | 461.14M | 399.67M | 222.36M | 117.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -98.09M | -124.37M | -28.76M | -56.97M | -84.41M |
| Investing | 67.41M | 87.36M | 45.38M | 55.35M | 69.43M |
| Financing | 3.16M | 5M | -11.36M | 21.67M | 22.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -97.85M | -177.98M | -215.71M | -216.22M | -124.37M |
| Investing | -9.05M | -58.8M | -175.34M | 109.59M | 87.36M |
| Financing | 105.4M | 465.28M | 211.5M | 81.84M | 5M |
| Market Cap | 52.98M |
| Price to Earnings Ratio | -0.39 |
| Price to Sales Ratio | 63.64 |
| Price to Cash Ratio | 3.7 |
| Price to Book Ratio | 0.45 |
| Dividend Yield | - |
| Shares Outstanding | 26.1M |
| Average Volume (1 week) | 466.16k |
| Average Volume (1 Month) | 642.33k |
| 52 Week Change | -81.96% |
| 52 Week High | 14.748 |
| 52 Week Low | 1.74 |
| Spread (Intraday) | 0.08 (3.85%) |
| Company Name | Inovio Pharmaceuticals Inc New |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.inovio.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
